David Domzalski, CEO at Foamix Pharmaceuticals Ltd. (FOMX), sold 66 shares at $5.95 ($393) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market sale of $393 FOMX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FOMX | SELL | 2019-04-03 | $19K | — | Filing → |
| FOMX | SELL | 2018-12-06 | $275 | — | Filing → |
| FOMX | SELL | 2018-11-20 | $20K | — | Filing → |